down arrow

Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
264.05
1.65 (0.63%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 10.14 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

255.00278.55

52 Week

145.00449.00
Valuation
Technical
Day's Volume

CASH

10.14 k (-49.57%) Volume

Shareholding (Dec 2024)

FII

0.02%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

62.06%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -5.48% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.84
  • The company has been able to generate a Return on Equity (avg) of 4.77% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Mildly Bearish range

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 792 Cr (Micro Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.48%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

2.92%

stock-summary
Price to Book

2.66

Revenue and Profits (1 Year):
Net Sales:
156 Cr
(Quarterly Results - Dec 2024)
Net Profit:
37 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.48%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.13%
0%
-16.13%
1 Year
47.76%
0.72%
48.48%
2 Years
95.52%
1.71%
97.23%
3 Years
9.79%
1.84%
11.63%
4 Years
-2.38%
1.98%
-0.4%
5 Years
6.21%
2.56%
8.77%

Latest dividend: 1.25 per share ex-dividend date: Aug-06-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.94%
EBIT Growth (5y)
-5.48%
EBIT to Interest (avg)
1.84
Debt to EBITDA (avg)
7.06
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.67
Tax Ratio
31.07%
Dividend Payout Ratio
-15.65%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
4.81%
ROE (avg)
4.77%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
33
Price to Book Value
2.66
EV to EBIT
16.10
EV to EBITDA
11.00
EV to Capital Employed
2.28
EV to Sales
2.01
PEG Ratio
0.01
Dividend Yield
0.48%
ROCE (Latest)
6.61%
ROE (Latest)
2.92%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.02%)

Promoter with highest holding

Krishna Datla (34.01%)

Highest Public shareholder

Rakesh Kantilal Shah (2.04%)

Individual Investors Holdings

32.31%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 58.10% vs 80.40% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 274.72% vs 126.34% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "156.47",
          "val2": "98.97",
          "chgp": "58.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "53.27",
          "val2": "25.12",
          "chgp": "112.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.08",
          "val2": "5.19",
          "chgp": "-21.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.91",
          "val2": "9.85",
          "chgp": "274.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.04%",
          "val2": "25.38%",
          "chgp": "8.66%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 24.25% vs -26.62% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 121.41% vs -150.68% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "173.16",
          "val2": "139.36",
          "chgp": "24.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.58",
          "val2": "-2.98",
          "chgp": "757.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.12",
          "val2": "8.47",
          "chgp": "-15.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-7.43",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.56",
          "val2": "-25.97",
          "chgp": "121.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.31%",
          "val2": "-2.14%",
          "chgp": "13.45%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 38.31% vs -2.64% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 363.46% vs 66.24% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "329.63",
          "val2": "238.33",
          "chgp": "38.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "72.85",
          "val2": "22.14",
          "chgp": "229.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.20",
          "val2": "13.66",
          "chgp": "-18.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-7.43",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "42.47",
          "val2": "-16.12",
          "chgp": "363.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.10%",
          "val2": "9.29%",
          "chgp": "12.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -4.08% vs -12.19% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 55.22% vs -433.33% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "335.66",
          "val2": "349.94",
          "chgp": "-4.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.51",
          "val2": "17.94",
          "chgp": "53.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.05",
          "val2": "20.78",
          "chgp": "-17.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.43",
          "val2": "-28.48",
          "chgp": "73.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-23.06",
          "val2": "-51.50",
          "chgp": "55.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.20%",
          "val2": "5.13%",
          "chgp": "3.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
156.47
98.97
58.10%
Operating Profit (PBDIT) excl Other Income
53.27
25.12
112.06%
Interest
4.08
5.19
-21.39%
Exceptional Items
0.00
0.00
Consolidate Net Profit
36.91
9.85
274.72%
Operating Profit Margin (Excl OI)
34.04%
25.38%
8.66%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 58.10% vs 80.40% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 274.72% vs 126.34% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
173.16
139.36
24.25%
Operating Profit (PBDIT) excl Other Income
19.58
-2.98
757.05%
Interest
7.12
8.47
-15.94%
Exceptional Items
0.00
-7.43
100.00%
Consolidate Net Profit
5.56
-25.97
121.41%
Operating Profit Margin (Excl OI)
11.31%
-2.14%
13.45%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 24.25% vs -26.62% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 121.41% vs -150.68% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
329.63
238.33
38.31%
Operating Profit (PBDIT) excl Other Income
72.85
22.14
229.04%
Interest
11.20
13.66
-18.01%
Exceptional Items
0.00
-7.43
100.00%
Consolidate Net Profit
42.47
-16.12
363.46%
Operating Profit Margin (Excl OI)
22.10%
9.29%
12.81%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 38.31% vs -2.64% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 363.46% vs 66.24% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
335.66
349.94
-4.08%
Operating Profit (PBDIT) excl Other Income
27.51
17.94
53.34%
Interest
17.05
20.78
-17.95%
Exceptional Items
-7.43
-28.48
73.91%
Consolidate Net Profit
-23.06
-51.50
55.22%
Operating Profit Margin (Excl OI)
8.20%
5.13%
3.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -4.08% vs -12.19% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 55.22% vs -433.33% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Fermenta Biotech Ltd stock-summary
stock-summary
Fermenta Biotech Ltd
Micro Cap
Pharmaceuticals & Drugs
Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951. The Company name was changed to 'DIL Limited' in September, 2003 and later on, the name was further changed to 'Fermenta Biotech Limited' on October 17, 2019. The Company is engaged in the business of manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations and environmental solution products and renting and selling of properties.
Company Coordinates stock-summary
Company Details
A-1501 DIL Complex Majiwada, Ghodbunder Road Thane One Thane (West) Maharashtra : 400610
stock-summary
Tel: 91-22-66230800/888
stock-summary
http://www.fermentabiotech.com
stock-summary
srikant.sharma@dil.net; contact@dil
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."